Bank Of America Corp Reata Pharmaceuticals Inc Transaction History

Bank Of America Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$79.22 - $105.37 $10.6 Million - $14.1 Million	-133,850 Reduced 60.38%	87,846 $8.96 Million
Q1 2023 May 12, 2023	BUY	$30.85 - $93.17 $576,432 - $1.74 Million	18,685 Added 9.2%	221,696 $20.2 Million
Q4 2022 Feb 10, 2023	BUY	$22.15 - $42.11 $719,321 - $1.37 Million	32,475 Added 19.04%	203,011 $7.71 Million
Q3 2022 Nov 14, 2022	BUY	$19.41 - $36.49 $1.59 Million - $2.98 Million	81,795 Added 92.17%	170,536 $4.29 Million
Q2 2022 Aug 12, 2022	BUY	$20.71 - $36.5 $219,712 - $387,228	10,609 Added 13.58%	88,741 $2.7 Million
Q1 2022 May 16, 2022	SELL	$24.12 - $39.6 $412,114 - $676,605	-17,086 Reduced 17.94%	78,132 $2.56 Million
Q4 2021 Feb 08, 2022	BUY	$25.61 - $110.96 $169,205 - $733,112	6,607 Added 7.46%	95,218 $2.51 Million
Q3 2021 Nov 15, 2021	BUY	$100.0 - $143.02 $2.92 Million - $4.17 Million	29,158 Added 49.04%	88,611 $8.92 Million
Q2 2021 Sep 13, 2021	BUY	$78.27 - $151.29 $4.65 Million - $8.99 Million	59,453 New	59,453 $8.42 Million

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.